The growing opioid crisis in America demands effective, evidence-based solutions that can help those struggling with addiction find lasting recovery. As a recognized leader in behavioral healthcare, Acadia Healthcare operates one of the nation’s most extensive networks of specialized treatment facilities, serving approximately 75,000 patients daily across their continuum of care.
Founded in 2005 and headquartered in Franklin, Tennessee, Acadia’s treatment network has grown to include more than 250 behavioral healthcare facilities throughout the United States. Their commitment to quality care is reflected in their patient outcomes – across their network of Comprehensive Treatment Centers (CTCs), an average of 72% of drug tests for illicit opioid use have been negative over a five-year period, significantly outperforming typical recovery rates.
The company’s approach combines FDA-approved medications with counseling and personalized support services through voluntary programs. This comprehensive strategy has proven highly effective at helping patients achieve and maintain recovery. According to recent data reported by The Jason Foundation, Acadia’s evidence-based treatment methods have helped thousands of individuals overcome substance use disorders.
One of Acadia’s key strengths lies in their specialized Comprehensive Treatment Centers, which provide medication-assisted treatment (MAT) for opioid use disorder. With 165 CTC locations across 33 states, they have established themselves as the largest provider of opioid addiction treatment in the United States. These centers utilize medications such as methadone and buprenorphine, combined with counseling and behavioral therapy, to create individualized treatment plans for each patient.
The company maintains rigorous quality standards across all facilities. Their CTCs have received full accreditation from CARF International, scoring in the 99th percentile across all 13 measured quality dimensions. This commitment to excellence extends throughout their nationwide treatment network, which includes acute inpatient hospitals, residential treatment centers, and outpatient clinics.
Beyond individual patient care, Acadia Healthcare has established strategic partnerships with leading healthcare systems across the country. These collaborations, as detailed in their corporate overview, help expand access to vital behavioral health services in underserved communities while maintaining high standards of care.
Recent patient satisfaction surveys demonstrate the effectiveness of their approach – 81% of patients, including those admitted involuntarily, reported feeling more hopeful after receiving care at Acadia facilities. The company has also provided over $500 million in uncompensated care since 2016, demonstrating their commitment to making treatment accessible to all who need it.
Acadia’s treatment model emphasizes the importance of comprehensive support services. Their programs address not only the immediate challenges of addiction but also the underlying mental health conditions and social factors that can impact recovery. This holistic approach includes providing resources for housing, employment, and community reintegration – essential elements for long-term recovery success.
Looking ahead, Acadia Healthcare continues to invest in expanding access to treatment while maintaining their focus on quality care. Their ongoing facility investments and technology upgrades demonstrate a commitment to advancing behavioral healthcare treatment standards nationwide.
Through their evidence-based approach, extensive network of facilities, and commitment to patient care, Acadia Healthcare stands at the forefront of addressing America’s behavioral health challenges. Their success in helping patients achieve recovery offers hope for communities affected by the ongoing opioid crisis.